Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

AppSwarm, Inc. (SWRM) Rides Momentum to Drive Application Development Initiatives for 2017

The company reported revenues of $589,000 for 2016 Mergers and acquisitions have enabled AppSwarm to enter the e-commerce, health and education segments In-house software development has produced virtual reality products and expanded the app incubation/acceleration program AppSwarm (OTC: SWRM), a publicly traded technology development and incubation acceleration firm, has experienced a momentum in 2017 that […]

No Eclipse in Sight for InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) as it Moves toward Clinical Trials

Proprietary biosynthesis process to produce cannabinoids Cannabinoid bioinformatics system that identifies optimal R&D pathways Lead candidate targeting billion dollar market Despite the awe-inspiring shadow cast by the moon on August 21, 2017, there’s no eclipse in sight for InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF). The Vancouver, Canada-based company continues its research and development (R&D) […]

SinglePoint, Inc. (SING) Shines among Diversified Players in the Legalized Cannabis Space

Commencing volume manufacturing, allowing ramp-up of distribution and sales Partnering with Bitcoin Capital to create proprietary bitcoin payment solution to serve cannabis industry SinglePoint, Inc. (OTC: SING) continues making great strides in its strategic diversification efforts and has become a compelling and diversified player within the cannabis market. In a recent article, SinglePoint was mentioned […]

India Globalization Capital’s (NYSE: IGC) Cannabis-Based Alzheimer’s Disease Treatment Increases Upside Potential

Alzheimer’s is a leading cause of dementia in adults in the United States IGC’s cannabis-based drug may reverse the buildup of beta-amyloid plaque Hyalolex and other phytocannabinoid-based drugs are fueling potential for the company’s market valuation growth Alzheimer’s disease is currently the sixth-leading cause of death in the nation and the most common cause of […]

PotNetwork Holdings Inc. (POTN) is “One to Watch”

Avoids federal legal issues by sourcing hemp grown outside U.S. and focusing on federally legal cannabidiol (CBD) Targets rapidly developing cannabis market, with cannabidiol alone expected to reach over $2 billion by 2020 Distribution already covers all 50 states, and is growing internationally PotNetwork Holdings, Inc. (OTC: POTN), based in Fort Lauderdale, Florida, is a […]

SinglePoint (SING) at Intersection of Two Explosive Markets: Bitcoin and Legal Cannabis

Industry leader projects cryptocurrency bitcoin, which has achieved $4,000 price, can reach $100,000 within five years Company provides processing solution for “unbankable” risk markets, such as legalized cannabis SinglePoint releases new investor relations kit that details its acquisition strategy, profiles key executives (http://dtn.fm/eZ4HE) SinglePoint, Inc. (OTC: SING) finds itself at the intersection of two fast-growth […]

India Globalization Capital, Inc. (NYSE: IGC) Focuses on Building Phytocannabinoid-based Pharmaceutical Portfolio

Core operations transitioned to phytocannabinoid-based therapies Four trial candidates targeting chronic pain, Alzheimer’s and other conditions Unique approach combining existing therapies with cannabinoids India Globalization Capital, Inc. (NYSE MKT: IGC) is developing disruptive new pharmaceutical therapies to fight a variety of ailments. Currently, the Maryland-based corporation has a pipeline of cannabis-based combination candidates under development […]

AppSwarm (SWRM) Completes Acquisition of MediaPlay, Anticipates Rapid Revenue Development

Poised for rapid revenue development following acquisition of MediaPlay Agreements in place with leading application stores to fast-track applications Company had $589,000 in revenues in 2016 and was able to eliminate more than $500,000 in corporate debt Technology development and incubation acceleration company AppSwarm, Inc. (OTC: SWRM) has announced its acquisition of MediaPlay, a multiplatform […]

 

From Our Blog

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Has the World’s Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes

March 31, 2026

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is in the unique position of holding the world’s only clinical-stage protein phosphatase 2A (“PP2A”) inhibitor, called LB-100. The LB-100 compound is a proprietary small-molecule PP2A inhibitor that is designed to target protein phosphatase 2A (“PP2A”), introducing a potential new treatment paradigm aimed at enhancing existing […]

Rotate your device 90° to view site.